You can read the full press release here . They expect it will be 10-14 months before a decision is known.
You might also like to read this plain language summary Trofinetide Treatment Demonstrates a Benefit Over Placebo for the Ability to Communicate in Rett Syndrome.
Trofinetide benefits the ability to communicate in Rett syndrome a plain language summary of the LAVENDER trialDownload
Acadia confirm submission to the EMA for approval of trofinetide (known as Daybue in US and Canada).